Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Vision Research, |
RCV001262104 | SCV001370891 | pathogenic | Leber congenital amaurosis | 2020-07-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003770362 | SCV004571427 | pathogenic | Cone-rod dystrophy 6; Leber congenital amaurosis 1 | 2023-07-14 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Phe883Leufs*13) in the GUCY2D gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GUCY2D are known to be pathogenic (PMID: 10951519, 11328726). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 982534). This premature translational stop signal has been observed in individual(s) with cone dystrophy and/or leber congenital amaurosis (PMID: 28966547, 31144483, 32165824). This variant is not present in population databases (gnomAD no frequency). |
Institute of Human Genetics, |
RCV004814038 | SCV005072209 | likely pathogenic | Retinal dystrophy | 2008-01-01 | criteria provided, single submitter | clinical testing | |
Juno Genomics, |
RCV004796397 | SCV005417277 | pathogenic | Leber congenital amaurosis 1 | criteria provided, single submitter | clinical testing | PM2_Supporting+PVS1+PM3_Strong |